Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
No participants in any clinical trial developed detectable anti-AOD9604 antibodies, even after 24 weeks of continuous exposure
Products are screened for heavy metals, microbials, and common contaminants
Some studies conclude that AOD 9604 may contribute to improved metabolic efficiency without altering growth hormone levels significantly
Oral dosing is mechanistically plausible because BPC-157 resists gastric acid better than most peptides, and may be preferable for GI-specific applications
By combining these agents in a single injection, the formulation may improve patient adherence to treatment protocols while potentially reducing the burden side effects or and multiple injections or medications, as determined by necessary by the prescribing physician
US$ 25.23
US$ 25.75
US$ 29.58
US$ 26.44
US$ 22.18
US$ 25.10
